Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae.
In spite of improved antimicrobial therapy, bacterial meningitis still results in brain damage leading to significant long-term neurological sequelae in a substantial number of survivors, as confirmed by several recent studies. Meningitis caused by Streptococcus pneumoniae is associated with a particularly severe outcome. Experimental studies over the past few years have increased our understanding of the molecular mechanisms underlying the events that ultimately lead to brain damage during meningitis. Necrotic damage to the cerebral cortex is at least partly mediated by ischemia and oxygen radicals and therefore offers a promising target for adjunctive therapeutic intervention. Neuronal apoptosis in the hippocampus may represent the major pathological process responsible for cognitive impairment and learning disabilities in survivors. However, the mechanisms involved in causing this damage remain largely unknown. Anti-inflammatory treatment with corticosteroids aggravates hippocampal damage, thus underlining the potential shortcomings of current adjuvant strategies. In contrast, the combined inhibition of matrix metalloproteinase and tumour necrosis factor-alpha converting enzyme protected both the cortex and hippocampus in experimental meningitis, and may represent a promising new approach to adjunctive therapy. It is the hope that a more refined molecular understanding of the pathogenesis of brain damage during bacterial meningitis will lead to new adjunctive therapies.
Meli
Damian N
DN
Institute for Infectious Diseases, University of Berne, Berne, Switzerland.
Christen
Stephan
S
Leib
Stephen L
SL
Täuber
Martin G
MG
D001925:Brain Damage, Chronic / Q000201:enzymology / Q000276:immunology / Q000382:microbiology* / Q000473:pathology*; D002560:Cerebrovascular Circulation; D006624:Hippocampus / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007249:Inflammation / Q000201:enzymology / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D007859:Learning Disabilities / Q000150:complications / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D008586:Meningitis, Pneumococcal / Q000150:complications / Q000201:enzymology / Q000276:immunology / Q000473:pathology*; D008666:Metalloendopeptidases / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D013296:Streptococcus pneumoniae / Q000276:immunology / Q000472:pathogenicity* / Q000502:physiology
D017382:Reactive Oxygen Species; D008666:Metalloendopeptidases